濮阳东方治病专业吗(濮阳东方医院看阳痿评价好很不错) (今日更新中)

ATLANTA (KGTV) - An Atlanta Delta flight was forced to return to the ground shortly after takeoff when black smoke began billowing from one of its engines.The Delta aircraft took off from Hartsfield-Jackson Atlanta International Airport Wednesday shortly after 6 p.m. EDT when the smoke was reported, according to airport officials. Multiple reports indicate the plane was heading for London's Heathrow Airport.About 43 minutes after takeoff, the plane returned to the ground and airport fire crews hosed down the engine. The plane was then towed back to its terminal.RELATED: Southwest passenger is first to die on a US airline since 2009No injuries were reported and the airport endured "minimal impact" to other operations, officials said.The emergency landing occurs one day after a Southwest Airlines plane blew an engine while traveling from New York to Dallas and was forced to land in Philadelphia.Jennifer Riordan, 43, was struck by shrapnel from the engine and partially sucked out of a window. She later died from her injuries. Seven other passengers were also injured in the incident. 1144

As New Haven, Connecticut, Fire Chief John Alston Jr. spoke to reporters about a spate of drug overdoses on Wednesday, he heard shouting coming from behind him."We're getting another call of a person," Alston said.He quickly helped coordinate the response, and then returned to the microphone.That scene came on the same day that as many as 71 people in the area of New Haven Green were believed to have overdosed on some form of K2, according to New Haven police spokesman Officer David Hartman.New Haven Green is a large park and recreation area in the city's downtown.The patients included people of various ages and demographics, Alston said."It's a nationwide problem. Let's address it that way," he said. "It's a nationwide problem that people are self-medicating for several different reasons, and every agency -- police, fire, medical hospitals -- all are strained at this time. This is a problem that's not going away."New Haven police said one person is in custody.Rick Fontana, director of Emergency Operations for New Haven, said the patients had symptoms of increased heart rates, decreased respiratory rates and a lot of vomiting. Some people were unconscious, others were semi-conscious.No one has died, but two individuals are considered to be in serious, life-threatening condition. Some individuals who were released from the hospital needed to be treated a second time for an additional apparent overdose, Fontana said.K2 is a synthetic cannabinoid related to marijuana that is frequently laced with other drugs, said Dr. Sandy Bogucki of the Yale School of Public Health.In two cases, Narcan was not effective in the field, but a high dose of Narcan at the hospital was effective in combating the overdose effects. Authorities confirm the substance was synthetic cannabis and that other drugs weren't involved in the substance.The response from emergency responders has been "tremendous," Fontana said.He said authorities have been treating and sometimes transporting six or seven people at one time and the actions of first responders have been "lifesaving.""We hope this is coming to an end, but it's too early to tell."The-CNN-Wire 2162

As questions arise over when a coronavirus vaccine should be granted FDA approval, the leaders of several major pharmaceutical companies announced they have signed a pledge not to rush the development of a vaccine.The companies, AstraZeneca, BioNTech, GlaxoSmithKline, Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi, released a joint statement on Tuesday confirming the pledge.The pledge includes the following points:Always make the safety and well-being of vaccinated individuals our top priority.Continue to adhere to high scientific and ethical standards regarding the conduct of clinical trials and the rigor of manufacturing processes.Only submit for approval or emergency use authorization after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA.Work to ensure a sufficient supply and range of vaccine options, including those suitable for global access.There has been pressure on both the FDA and manufactures to develop and approve a vaccine for the coronavirus. There have been more than 190,000 coronavirus-related deaths in the US since March, and the economic impact of the virus has cost millions of jobs.While most developed countries have not had the same public health pain as the US, the economic impact of the virus has been felt worldwide. The International Monetary Fund estimates a nearly 5% loss in global GDP in 2020.In Russia, the country claimed to begin distributing a coronavirus vaccine despite US-based vaccine candidates likely being months away from being able to demonstrate efficacy.The pressure domestically has also ratcheted up as President Donald Trump has suggested a vaccine could be ready by this fall’s presidential election."We're going to have a vaccine very soon... maybe even before a very special date, you know what date I'm talking about,” Trump said on Monday.In late August, the CDC told states to begin to prepare distributing a vaccine by Nov. 1. But Surgeon General Jerome Adams said that just because states will be ready to help distribute a vaccine on Nov. 1 does not mean a vaccine will be ready by then."We've always said that we're hopeful for a vaccine by the end of this year or the beginning of next year,” Adams told Good Morning America."We want to make sure states are available to distribute it," he added.The companies signing on the pledge said that the FDA has strict protocols for vaccine candidates. A typical vaccine trial takes one to three years, but the companies believe only a safe and effective vaccine will be granted approval.“FDA has established clear guidance for the development of COVID-19 vaccines and clear criteria for their potential authorization or approval in the US,” the companies wrote in the pledge. “FDA’s guidance and criteria are based on the scientific and medical principles necessary to clearly demonstrate the safety and efficacy of potential COVID-19 vaccines. More specifically, the agency requires that scientific evidence for regulatory approval must come from large, high quality clinical trials that are randomized and observer-blinded, with an expectation of appropriately designed studies with significant numbers of participants across diverse populations.” 3296

As our country works to rebound, companies are managing the pressure of keeping workplaces safe.Employers are taking precautions ahead of Thanksgiving with concerns about the coronavirus spreading over the holiday.Companies are doing everything from issuing memos, reminding workers about the public health guidance on gatherings and travel, to asking workers to sign pledges they'll keep gatherings small.But there are limits to how much say your boss has on what you're doing outside of work.“They are allowed to inquire about what their travel plans might be, what their off-duty conduct might be and they can ask employees to disclose that information,” said Christine Lamb, an employment attorney with Fortis Law Partners.Lamb says many states prevent employers from discriminating against workers who are doing things outside of work that are lawful.But if you aren't following policies your work put in place for COVID-19, they can ask you to go through some type of coaching or counseling.Lamb advises companies against checking in on their workers on social media.“You might have an employee who is at a gathering of 50 people and they're not posting anything on social media. The employer might not know what's going on and another employee that posts a photograph of them with 10 people on social media, there's just a risk of that unequal application of the rules,” said Lamb.She says one thing employers should be thinking about now is what does next week look like for the company post-Thanksgiving. That includes having a plan for people to work from home if that's possible.One drug maker told the Wall Street Journal that it's offering workers a paid 2-week quarantine if they need it after the holiday, where they'll be expected to work from home. 1773

As President Donald Trump and Vice President Mike Pence prepared to gather for their weekly lunch in August 2017, the President told his staff to add two more plates.Both men had just welcomed new chiefs of staff -- retired Marine Corps Gen. John Kelly and Nick Ayers, a 34-year-old Republican political consultant from Georgia -- and Trump decided to wave the pair into his private dining room off the Oval Office.Until then, a Cabinet member would occasionally join them, but the meals were largely a chance for Trump and Pence to spend time together alone, chatting about politics, policy and whatever popped into Trump's mind -- sometimes prompted by the television in the room tuned to Fox News.But in August 2017, the lunch went from a regular tête-à-tête to a four-man affair, one that became a more formal opportunity for the two offices to coordinate on strategy, policy and scheduling. For Ayers, Pence's new chief of staff, they were useful in another, perhaps more important way: he now had regular face-time with the President. With each passing lunch, Trump grew to know and like Ayers more, two sources close to the President said, allowing Ayers to build a strong personal rapport that could end up paying dividends.As the President considers replacing his chief of staff, Ayers has emerged as a top contender, multiple people familiar with the situation told CNN. Interviews with nearly two dozen current and former White House officials, former Ayers colleagues, sources close to the President and Republican congressional staffers portray an ambitious aide who has worked to insulate his current boss from the chaos of the West Wing, while also angling for a bigger job that would place him squarely in the middle of it.Trump has begun to envy the smoothly operating vice president's office, which Ayers has managed to keep distanced from the daily scrum and scandal of the White House. Ayers has cultivated key allies, including Ivanka Trump and Jared Kushner. He also boasts an impressive track record in Republican politics that could serve the President well in the run-up to his 2020 re-election.But Ayers' meteoric rise has also earned him his fair share of critics, including a few inside the White House. While plans were floated earlier this month for Ayers to become the new chief of staff, multiple sources told CNN, they have stalled amid the President's reluctance to fire Kelly -- who typically does the firing for Trump -- and the backbiting Ayers has faced from some of his West Wing colleagues.Several of Trump's top advisers have voiced concerns to him about Ayers, with some threatening to quit if he is tapped for the job. One of Ayers' top West Wing detractors during the process has been Kellyanne Conway, the combative counselor to the President who vehemently opposed Ayers' hire as Pence's chief of staff last year, two former White House officials and a source familiar with the matter said.Conway disputes those allegations, telling CNN: "I have zero beef with Nick Ayers."Outside the White House, former colleagues of Ayers say his relative youth and outsized ego -- conspicuous even in a world known for naked ambition and self-aggrandizement -- have rubbed fellow political operatives the wrong way. His allies say that people are just jealous or insecure."I think every job he's ever had he's been one of the youngest people to ever have it. And I think that's threatening to some people," said Alex Conant, who worked with Ayers on former Minnesota Gov. Tim Pawlenty's 2012 presidential campaign.Though he's only 36, Ayers has amassed a small fortune that, according to recent financial disclosures, is between million to million. That's been built up through financial investments, fees generated by his own political consulting firm and his former role as a principal in an ad-buying firm called Target Enterprises, which has served as the media buyer on nearly every race Ayers has worked on since he joined in 2011.The arrangement allowed Ayers to earn a consultant's salary while also influencing campaign spending in a way that benefited him financially, a practice that is not illegal but has raised consternation among fellow consultants. A source familiar with the matter insisted all of the candidates Ayers has serviced were aware of the financial arrangement behind his consulting.Still, his finances and involvement with political dark money groups could become political baggage down the road. One of them, Freedom Frontier, for whom he consulted, is the subject of two recent ethics complaints, the most recent of which was filed with the IRS on Tuesday. That complaint, filed by Citizens for Responsibility and Ethics in Washington, contends the group's political spending exceeded legal limits in violation of campaign finance laws.Efforts to reach officials with Freedom Frontier for comment were unsuccessful.  4901

来源：资阳报